MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

Search

Fresenius Medical Care AG & Co KGaA

Geschlossen

25.65 3.93

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

24.68

Max

25.95

Schlüsselkennzahlen

By Trading Economics

Einkommen

-146M

119M

Verkäufe

325M

5.1B

KGV

Branchendurchschnitt

24.9

63.778

EPS

0.455

Dividendenrendite

2.58

Gewinnspanne

2.338

Angestellte

111,513

EBITDA

-565M

281M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+10.95% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

2.58%

2.39%

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

933M

15B

Vorheriger Eröffnungskurs

21.72

Vorheriger Schlusskurs

25.65

Technischer Score

By Trading Central

Vertrauen

Neutral Evidence

Fresenius Medical Care AG & Co KGaA Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

21. März 2025, 08:19 UTC

Market Talk

Fresenius Medical Care's Revenue Estimates Lowered by Jefferies on U.S. Volume Concerns -- Market Talk

25. Feb. 2025, 10:27 UTC

Market Talk
Ergebnisse

Fresenius Medical Care's U.S. Volume Growth Is Unlikely to Reassure Investors -- Market Talk

15. Juli 2024, 08:17 UTC

Market Talk

Fresenius Medical Care, DaVita Brace for Competition, Shift to Home Dialysis -- Market Talk

3. Mai 2024, 08:20 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Fresenius' Disposal of Part of Its Rehabilitation Business Seems Positive -- Market Talk

Peer-Vergleich

Kursveränderung

Fresenius Medical Care AG & Co KGaA Prognose

Kursziel

By TipRanks

10.95% Vorteil

12-Monats-Prognose

Durchschnitt 27.45 USD  10.95%

Hoch 28.9 USD

Tief 26 USD

Basierend auf 5 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Fresenius Medical Care AG & Co KGaA – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

5 ratings

2

Buy

3

Halten

0

Sell

Technischer Score

By Trading Central

24.68 / 24.87Unterstützung & Widerstand

Kurzfristig

Neutral Evidence

Mittelfristig

Bullish Evidence

Langfristig

Weak Bullish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Fresenius Medical Care AG & Co KGaA

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.